|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Accounts receivable | |||||||||||||||||
| Nonrelated Party | |||||||||||||||||
| Related Party | |||||||||||||||||
| Inventories | |||||||||||||||||
| Short-term investments - related parties | |||||||||||||||||
| Finance lease receivables, current - related parties | |||||||||||||||||
| Income tax recoverable | |||||||||||||||||
| Customer loans receivable, current | |||||||||||||||||
| Income tax receivable | |||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||
| Total, Other receivables | |||||||||||||||||
| Other receivables - related parties | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Marketable securities held in Trust Account | |||||||||||||||||
| Non-current assets: | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Long-term investments, net | |||||||||||||||||
| Nonrelated Party | |||||||||||||||||
| Related Party | |||||||||||||||||
| Total long-term investments, net | |||||||||||||||||
| Equity method investments | |||||||||||||||||
| Goodwill, net | |||||||||||||||||
| Cryptocurrencies | |||||||||||||||||
| Finance lease receivables, non-current - related parties | |||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||
| Finance lease right-of-use assets | |||||||||||||||||
| Deferred tax assets | |||||||||||||||||
| Customer loans receivable, non-current | |||||||||||||||||
| Long-term prepayments | |||||||||||||||||
| Long-term investments in MCs – related parties | |||||||||||||||||
| Long-term investments in MCs - related parties | |||||||||||||||||
| Other assets | |||||||||||||||||
| Total non-current assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Nonrelated Party | |||||||||||||||||
| Related Party | |||||||||||||||||
| Total accounts payable | |||||||||||||||||
| Accrued expenses | |||||||||||||||||
| Aggregate principal amount | |||||||||||||||||
| Promissory Note | |||||||||||||||||
| Bank and other borrowings, current | |||||||||||||||||
| Notes payables, current - related parties | |||||||||||||||||
| Franchise tax payable | |||||||||||||||||
| Advances from customers | |||||||||||||||||
| Nonrelated Party | |||||||||||||||||
| Related Party | |||||||||||||||||
| Income tax payable | |||||||||||||||||
| Excise tax payable | |||||||||||||||||
| Operating lease liabilities, current | |||||||||||||||||
| Finance lease liabilities, current | |||||||||||||||||
| Accrued liabilities and other current liabilities | |||||||||||||||||
| Due to related party | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Deferred underwriting fee payable | |||||||||||||||||
| Non-current liabilities: | |||||||||||||||||
| Bank and other borrowings, non-current | |||||||||||||||||
| Notes payables, non-current - related parties | |||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||
| Operating lease liabilities, non-current | |||||||||||||||||
| Finance lease liabilities, non- current portion | |||||||||||||||||
| Other liabilities | |||||||||||||||||
| Total Non-current Liabilities | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Class A common stock subject to possible redemption, 188,645 and 1,922,750 shares at redemption value of $11.59 and $10.72 per share as of June 30, 2024 and December 31, 2023, respectively | |||||||||||||||||
| Class A Common Stock | |||||||||||||||||
| Total class A common stock subject to possible redemption, 188,645 and 1,922,750 shares at redemption value of $11.59 and $10.72 per share as of June 30, 2024 and December 31, 2023, respectively | |||||||||||||||||
| Stockholders’ equity: | |||||||||||||||||
| Preferred stock ($0.0001 par value, 20,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025) | |||||||||||||||||
| Common stock ($0.0001 par value, 400,000,000 shares authorized, 103,881,251 shares issued, and 102,576,943 shares outstanding as of June 30, 2026 and December 31, 2025) | |||||||||||||||||
| Class A Common Stock | |||||||||||||||||
| Total common stock ($0.0001 par value, 400,000,000 shares authorized, 103,881,251 shares issued, and 102,576,943 shares outstanding as of June 30, 2026 and December 31, 2025) | |||||||||||||||||
| Additional paid in capital | |||||||||||||||||
| Treasury stock (at cost, 1,304,308 shares as of June 30, 2026 and December 31, 2025) | |||||||||||||||||
| Retained earnings | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Total SBC Medical Group Holdings Incorporated stockholders’ equity | |||||||||||||||||
| Non-controlling interests | |||||||||||||||||
| Total stockholders' equity | |||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||
Loading...
